Know Cancer

or
forgot password

Non Interventional Study Dealing With the Use of Bevacizumab (Avastin®) in Patients With Epithelial Ovarian Cancer, Fallopian Tube or Primary Peritoneal and Treated in First-line Therapy


N/A
18 Years
N/A
Open (Enrolling)
Female
Epithelial Ovarian Cancer

Thank you

Trial Information

Non Interventional Study Dealing With the Use of Bevacizumab (Avastin®) in Patients With Epithelial Ovarian Cancer, Fallopian Tube or Primary Peritoneal and Treated in First-line Therapy


Population: Patients aged 18 years and older with an epithelial ovarian cancer, fallopian
tube or primary peritoneal or witch it was decided to initiate a process comprising of
Bevacizumab (Avastin ®) in first-line therapy


Inclusion Criteria:



- Patients aged 18 years and over,

- Patients with an epithelial ovarian cancer, fallopian tube or peritoneal who will
receive bevacizumab (Avastin ®) in first-line therapy

- Patients should be informed of the study orally and should not have any objection
their data to be processed.

Exclusion Criteria:

- Patient participation in a clinical trial

- Patient non-affiliated to a social security scheme.

Type of Study:

Observational [Patient Registry]

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Safety according to CTCAE v4.0 criteria

Outcome Description:

To assess patient safety and the tolerance of bevacizumab andministered regarding the daily practice of the oncologist.

Outcome Time Frame:

Patient will be followed dureing 36 months

Safety Issue:

Yes

Principal Investigator

Dominique BERTON-RIGAUD, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

ICO de l'Ouest, Site René Gauducheau - Saint-Herblain

Authority:

France: The National Commission for Informatics and Liberties (CNIL in french)

Study ID:

ENCOURAGE (GINECO-OV123)

NCT ID:

NCT01832415

Start Date:

April 2013

Completion Date:

January 2018

Related Keywords:

  • Epithelial Ovarian Cancer
  • First line treatment
  • Ovarian cancer
  • Avastin
  • fallopian tube or primary peritoneal
  • Ovarian Neoplasms
  • Fallopian Tube Neoplasms
  • Neoplasms, Glandular and Epithelial

Name

Location